Antitumor activity of nimotuzumab in combination with cisplatin in lung cancer cell line A549 in vitro

Nimotuzumab, a humanized IgG1 monoclonal antibody against epidermal growth factor receptor (EGFR), increases radiosensitivity in lung cancer. Cisplatin is an effective antitumor agent in lung cancer. In the present study, the antitumor activity of nimotuzumab combined with cisplatin was investigated...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncol Lett
Huvudupphovsmän: Yang, Yanhong, Zhou, Wenwen, Wu, Jiandong, Yao, Lixin, Xue, Lei, Zhang, Qianyi, Wang, Zhenzhen, Wang, Xiaoyu, Dong, Shu, Zhao, Jiangman, Yin, Duanduan
Materialtyp: Artigo
Språk:Inglês
Publicerad: D.A. Spandidos 2018
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5840536/
https://ncbi.nlm.nih.gov/pubmed/29552167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.7923
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk